Literature DB >> 16869795

Renal allograft injury is associated with urinary tract infection caused by Escherichia coli bearing adherence factors.

J C Rice1, T Peng, Y-F Kuo, S Pendyala, L Simmons, J Boughton, K Ishihara, S Nowicki, B J Nowicki.   

Abstract

Urinary tract infections are the most common infection in renal transplant patients and Escherichia coli (E. coli) is the most common clinical isolate. Although acute allograft injury (AAI) secondary to urinary tract infection (UTI) has been reported, the incidence of AAI associated with UTI, the virulence factors express by uropathic E. coli and whether virulence factors are associated with renal allograft outcome have not been described. We collected E. coli from our renal transplant patients with UTI, determined O:H serotypes, P and Dr fimbriae expression and the clinical presentation and allograft function during the UTI and post-UTI period. Pyelonephritis occurred in 40% of our patients, 82% of which had AAI (>20% increase in SCr). Sixty-two percent of E. coli isolates that expressed P fimbriae were associated with AAI, whereas only 29% that did not express P fimbriae had AAI (p = 0.03). The pattern of P fimbriae and O serotypes differed from reported isolates, as the P fimbriae PapG class II and the O25 serotype were the most common. Dr adhesin was expressed on 7 isolates, including 2 of 3 with urosepsis. We propose a unique pattern of uropathogenic serotypes and adherence factors contribute to acute allograft injury in renal transplant patients with UTI.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16869795     DOI: 10.1111/j.1600-6143.2006.01471.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  15 in total

1.  Complicated pyelonephritis: unresolved issues.

Authors:  Lindsay E Nicolle
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

2.  The role of host factors and bacterial virulence genes in the development of pyelonephritis caused by Escherichia coli in renal transplant recipients.

Authors:  Priscila Reina Siliano; Lillian Andrade Rocha; José Osmar Medina-Pestana; Ita Pfeferman Heilberg
Journal:  Clin J Am Soc Nephrol       Date:  2010-05-06       Impact factor: 8.237

3.  Urinary tract infection following kidney transplantation: frequency, risk factors and graft function.

Authors:  Christopher Imokhuede Esezobor; Peter Nourse; Priya Gajjar
Journal:  Pediatr Nephrol       Date:  2011-11-06       Impact factor: 3.714

Review 4.  [Urinary tract infections after kidney transplantation: Essen algorithm for calculated antibiotic treatment].

Authors:  S Becker; O Witzke; H Rübben; A Kribben
Journal:  Urologe A       Date:  2011-01       Impact factor: 0.639

Review 5.  Pathogenesis of human diffusely adhering Escherichia coli expressing Afa/Dr adhesins (Afa/Dr DAEC): current insights and future challenges.

Authors:  Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

6.  Urinary tract infections in renal transplant recipients.

Authors:  George Alangaden
Journal:  Curr Infect Dis Rep       Date:  2007-11       Impact factor: 3.725

7.  Escherichia coli sequence type ST131 as an emerging fluoroquinolone-resistant uropathogen among renal transplant recipients.

Authors:  James R Johnson; Brian Johnston; Connie Clabots; Michael A Kuskowski; Swaroop Pendyala; Chitrita Debroy; Bogdan Nowicki; James Rice
Journal:  Antimicrob Agents Chemother       Date:  2009-11-16       Impact factor: 5.191

8.  Urinary tract infections and asymptomatic bacteriuria in renal transplant recipients.

Authors:  Rabi Yacoub; Nader Kassis Akl
Journal:  J Glob Infect Dis       Date:  2011-10

9.  Stented ureterovesical anastomosis in renal transplantation: does it influence the rate of urinary tract infections?

Authors:  Zoltan Mathe; J W Treckmann; M Heuer; A Zeiger; S Sauerland; O Witzke; A Paul
Journal:  Eur J Med Res       Date:  2010       Impact factor: 2.175

10.  Urinary tract infections in children after renal transplantation.

Authors:  Ulrike John; Markus J Kemper
Journal:  Pediatr Nephrol       Date:  2008-01-16       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.